Cardiotoxicity

Haptoglobin gene expression in the blood appeared associated with anthracycline-related cardiomyopathy among childhood cancer survivors, according to study results.

An expert panel of pediatric cardiologists and oncologists issued its inaugural cardio-oncology guidelines for the management of pediatric patients receiving anticancer therapy.

In this edition, the importance of vaccination after cell therapy, artificial intelligence may help predict cardiotoxicity, experimental breast cancer vaccine generates immune response, and more.

Artificial intelligence models can help predict cardiotoxicity risk among patients with renal cell carcinoma treated with VEGF receptor inhibitors, according to study results.

The European Society of Cardiology task force on cardio-oncology has issued its inaugural guideline for the prevention and management of cardiotoxicity before, during and after adult patients are treated with anticancer therapies.

Patients who received the chemotherapy drug doxorubicin for childhood cancer and harbor a specific genetic mutation near the KCNK17 gene experienced significantly greater risk for heart disease later in life, study results have shown.

Women with breast cancer exhibited higher risk for heart failure, cardiomyopathy and other cardiovascular disease events than women without breast cancer, according to prospective study results published in Journal of Clinical Oncology.

Exposure to toxic metals, including arsenic, cadmium and titanium, among employees at a car assembly plant was linked to subclinical level of atherosclerosis in three vascular territories, researchers reported.

Researchers found no association between female sex and HF in adult patients treated with anthracyclines for non-hormone-dependent tumors, according to a presentation from the American Heart Association Scientific Sessions.

Although more than 25% of contemporary FDA-approved cancer therapies required cardiovascular warnings, post-marketing issuance of the warnings trailed clinical approval by several years, according to a research letter in JAMA Oncology.